DrugMay 7, 2014
Lupron Depot recall — FDA D-1290-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
10,690drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 352
10,690 detailed records are currently available in this category.
DrugMay 7, 2014
SODIUM CHLORIDE 0.9 % Sodium Chloride Injection USP in PAB 50 mL partial fill in 100 mL PAB recall — FDA D-1265-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container recall — FDA D-1269-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
Fluoxetine Capsules USP, 10 mg, 100-count bottles recall — FDA D-1281-2014
Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.
Class IIFDA: TerminatedTeva Pharmaceuticals USA
DrugMay 7, 2014
Fluoxetine Capsules, USP, 20 mg, 30-count bottles recall — FDA D-1279-2014
Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
Class IIFDA: TerminatedLegacy Pharmaceutical Packaging
DrugMay 7, 2014
B. Braun Medical TrophAmine (10% Amino Acid Injection), 500 mL Container recall — FDA D-1273-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
B. Braun Medical 15% Amino Acids Injection PBP Glass, 1000 mL, Catalog No recall — FDA D-1272-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
Apotex Risperidone Oral Solution, 1 mg/mL, 30 mL bottle recall — FDA D-1299-2014
Failed Impurities/Degradation Specifications: Out of Specification for an impurity at the 18 month stability time point.
Class IIIFDA: TerminatedApotex Inc.
DrugMay 7, 2014
B. Braun Medical ProcalAmine recall — FDA D-1274-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
LUPRON DEPOT-PED recall — FDA D-1289-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose, 6000 mL Ambu-Flex II container recall — FDA D-1276-2014
Non-Sterility: Complaints of leaks and particulate matter identified as mold in the solution bag and the overpouch.
Class IFDA: TerminatedBaxter Healthcare Corp.
DrugMay 7, 2014
B. Braun Medical 6.9% FreAmine HBC (Amino Acid Injection), partial fill container 750 mL in recall — FDA D-1271-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
B. Braun Medical Hyperlyte CR recall — FDA D-1275-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugMay 7, 2014
Medisca Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and recall — FDA D-1263-2014
Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.
Class IFDA: TerminatedMedisca Inc.
DrugMay 7, 2014
Lupron Depot recall — FDA D-1288-2014
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Class IIFDA: TerminatedAbbVie Inc.
DrugMay 7, 2014
B. Braun Medical Ceftriaxone for Injection and Dextrose Injection, 1 g in Duplex, 50 mL recall — FDA D-1266-2014
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Class IFDA: TerminatedB. Braun Medical Inc.
DrugApr 30, 2014
Hospira Potassium Chloride for Inj recall — FDA D-1261-2014
Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide
Class IIFDA: TerminatedHospira Inc.
DrugApr 30, 2014
LORATADINE AND PSEUDOEPHEDRINE SULFATE Non-Drowsy 24 Hour Formula Allergy Relief and Nasal recall — FDA D-1256-2014
Defective Container: An unacceptable level of blister defects have been identified in Loratadine and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg.
Class IIFDA: TerminatedOhm Laboratories, Inc.
DrugApr 30, 2014
Brookfield Prescription Center Glycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials recall — FDA D-1252-2014
Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.
Class IFDA: TerminatedBrookfield Prescription Center Inc.
DrugApr 30, 2014
GlaxoSmithKline Consumer Healthcare Nicorette Lozenge and NicoDerm CQ, nicotine polacrilex recall — FDA D-1247-2014
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class IIIFDA: TerminatedGlaxoSmithKline Consumer Healthcare;…
DrugApr 30, 2014
NICORETTE Nicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count recall — FDA D-1241-2014
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class IIIFDA: TerminatedGlaxoSmithKline Consumer Healthcare;…
DrugApr 30, 2014
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 recall — FDA D-1246-2014
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class IIIFDA: TerminatedGlaxoSmithKline Consumer Healthcare;…
DrugApr 30, 2014
GlaxoSmithKline Consumer Healthcare Nicotine polacrilex lozenge, 2 mg, Cherry Flavor, 72 recall — FDA D-1238-2014
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class IIIFDA: TerminatedGlaxoSmithKline Consumer Healthcare;…
DrugApr 30, 2014
NICORETTE Nicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count recall — FDA D-1240-2014
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
Class IIIFDA: TerminatedGlaxoSmithKline Consumer Healthcare;…
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.